However, a recent report suggested that LAPTM5 is downregulated in human cancers, such as neuroblastoma, and that low levels of LAPTM5 are associated with poor prognosis (Nuylan et al., 2016). The gene discussed is LAPTM5; the disease is neuroblastoma.